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ABSTRACT 
Obesity is a chronic disorder of global prevalence and associated with morbidity and mortality. So the attention is being focused on the 
investigation of plant based drug  used in the traditional  medicine for the treatement of  obesity .The present study is undertaken to evaluate 
the anti- hyperlipidimic and anti-obesity activity of Sesbania  grandiflora flower extract in High Fatty Diet induced Obesity in rats.  Female 
wistar rat weighing 150-200 g were divided into different groups i.e. normal control, Negative control [Hfd control], orlistat [STD control], 
extract of sesbania grandiflora flower contain 200mg/kg and 400mg/kg group. .Obesity was assessed by measuring biochemical parameters 
such as glucose, triglyceride, serum cholesterol, HDL [High Density Lipoprotein], LDL [Low Density Lipoprotein] level. The results of the 
present investigation demonstrated that, the extract of sesbania grandiflora flower at 200mg/kg and 400 mg/kg shows significant protective 
effects on biochemical parameters such as body weight, BMI, obesity index, and adiposity index respectively as compared to HFD [High Fatty 
Diet] control group. Similarly, serum glucose, triglyceride, total cholesterol HDL, LDL was found to be attenuated as compare to HFD control 
group. The ethanolic extract of sesbania grandiflora flower exhibit significant anti-hyperlipidemia and anti- obesity activity in High fatty diet 
induced in obese rat. 
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INTRODUCTION 
Obesity is the condition in which fat accumulates the body, 
which exhibits adverse effect on health and life expectance. 
According to the WHO, obesity is one of the five leading 
causes of death all around the world. It is chronic disorder 
caused by genetic and environmental factors.[1] It 
characterized by high cholesterol level indicated by increase 
in level  of fatty acid; alteration in metabolism; insulin 
resistence;lethargy ,stone in gall bladder , hypertension, 
breathing deficiency; cancer , liver disorder arthritis. 
Overweight   and obesity are the most common nutritional 
disorders in developed countries. Individuals   having BMI 
between 25 and 30/ kg/m2 are defined as obese [2]. Obesity 
accompanied by hyperlipidemia which is indicated by 
abnormally high concentration of lipid in blood. Nowadays 
[3,4] , change in human lifestyle and high energy diet have 
been increased the incidence of obesity and even have 
become risk factor to the population. There are several 
pharmacological substances available as antiobesity drugs, 
however they have several hazardous effect and hence 
natural products have been used for treating obesity in 
many Asian countries.[5] The potential of natural products 
for the treatement of obesity  is still largly unexplored and 
can be excellent for the safe and effective development of 
antiobesity drug.[6] 
 Currently the drug available in the market for treatement of 
obesity can be divided into two measure classes one being 
orlistat which reduces the fat absorption of [7,8] pancreatic 
lipase and second is subutramine which is an  appetite 
suppresment. The synthetic drug having high cost, and it 
show the potentially hazardous side effect, So the need of 
natural products against the obesity is under exploration [9] 
which may be an alternative strategy for developing 
effective, safe antiobesity drug. The antiobesity effect of 
natural products from more diverse source.  Sesbania 
grandiflora scientifically reported to wound healing activity, 
Antimicrobial activity,  Antioxidant, Antiulcer Activity[10]. 
.posses; there is also reported paper for its hypolipidemic 
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activity. Hyperlipidemia is one of the causes for the 
development of obesity and Sesbania grandiflora has 
reported for its hypolipidemic purpose while there is no any 
scientific report available for its antiobesity activity. Thus in 
the present investigation, the plant extract of Sesbania 
grandiflora has been used to evaluate its antihyperlipidemic 
and antiobesity activities in high fatty diet induce obese rats. 
Materials and methods 
Plant Material : 
Fresh flowers of Sesbania grandiflora were collected from 
the local area of Pune and the collected in the month of 
October and November and authenticated by Dr   Gautam, 
Botanist , Pune, India .The sample was identified at the 
national herbarium where some specimen was already 
available with the number B/II/293/0206776. 
Preparation of plant extract:     
A weighed quantity (50g) of the air-dried powdered flowers 
of sesbania grandiflora was drawn and then it was extracted 
with 90% ethanol in a Soxhelt extractor. The hydroalcoholic 
extract was concentrated in a rotary flash evaporator at a 
temperature not exceeding 50˚ C to get a solid residue. 
Different concentration (200mg/kg and 400 mg/kg p.o.) of   
hydroalcoholic extract of flowers of Sesbania grandiflora was 
given according to body weight of animals. 
Experimental Animals 
 The present study, wistar rat of female 200-250mg/kg body 
weight were used.  Under the standard environmental 
condition   of the temperature 25± °C, with a 12 h light/dark 
cycle and humidity around (50 ± 5) %. During 
acclimatization, the rats were randomized into experimental 
and control groups and housed individually in sanitized 
cages housed with sterile husk as bedding. The animals had 
free access to food and water ad libitum throughout study. 
All experimental procedures were carried out between 9-16 
hours with the Institutional Animal Ethical Committee 
approved protocol (CPCSEA/IAEC/PC-06/01-2K18) for the 
study. 
High fat diet induced obesity in rat 
In the present investigation, obesity in experimental animal 
was induced by daily use of high fatty diet (Table 1). HFD is 
reported to result in obesity and its associated condition 
such as metabolic alterations, hyperphagia reduced lipolytic 
activity in fat tissue , reduction in leptin secretion and or 
sensitivity, hypothalamic neuron apotosis impairement of 
mitochondrial metabolism and insulin  resistance.  
Table 1: Composition of High Fatty Diet 
S.N. Ingrediant Quntity 
1 Cholesterol 10 G/KG 
2 Casine 280G/KG 
3 Lard/Tallo Oil 300G/KG 
4 Starch 260 G/KG 
5 Cellulose    50 G/KG 
6 Soya Oil 50 G/KG 
7 Vit + Minrals 50 G/KG 
 
Experimental induction of obesity in rat:-   
For induction   of obesity, the animals were fed with HFD for 
6 week followed by drug treatments (S.Grandiflora flower 
extract, std orlistat). After confirmation of significant 
obesity, the animals were group into different group each 
contains 6 rats. In the second phase, the animals were 
treated with Sesbania grandiflora (200 and 400 mg/kg p.o.) 
and standard Orlistat IR capsule (30 mg/kg) for further 6 
week along with HFD. While the normal control animals 
were fed with standard plain diet. Antiobesity and 
antihyperlipidemic activity was confirmed by evaluating the 
parameters such as lipid profile, daily food intake and body 
weight respectively. At the end of the study all the animals 
were sacrificed and liver was isolated for histopathological 
examination.   
Body   weight: 
The body weight (gm) was recorded on day one and then 
weekly consecutively for 49 days using a digital weighing 
balance. In addition to this, the daily food intake for each 
group was measured Weekly for 49 days. 
Biochemical Estimations 
On the 49th day of the experiment all the animals were 
sacrificed by cervical dislocation, and blood samples were 
collected by carotid bleeding separately into  sterilized dry 
centrifugation tubes and allowed to stand for 30 minutes at 
20–25°C. The clear serum was separated at 2500 rpm for 
10 min using a centrifuge. The levels of serum glucose, total 
TC, HDL-C, TG, LDL-C, were determined to analyze using 
Chariot Prince Biochemistry Analyzer. 
Relative organ weight 
The above-mentioned organs were quickly removed and 
weighed individually. Each organ to body weight ratio 
(relative organ weight) was calculated as (weight of 
organ/body weight of rat on the day of sacrifice) *100%. 
Histopathological Examination 
Liver, excised from each treatment group were subjected to 
histopathological examinations. After fixing the tissues in 10 
% formalin, they were dehydrated and mounted in paraffin 
blocks. The sections of 3-5 µ thickness were cut and stained 
with hematoxylin-eosin stain. 
Statistical Analysis: 
 Statistical analysis was carried out using the GraphPad  
Instat 3. All of the data are shown as the mean ± standard 
error of the mean (S.E.M) and were analyzed using one-way 
analysis of variance (ANOVA). Significant differences 
between theHFD control and experimental groups were 
determined using Dunnet multiple comparison test, P<0.001 
was considered significant. 
Result 
Effects of High-Fat Diet and S. Grandiflora flower extract 
on Food Intake and Body Weight 
There was no significant difference in all of the treatment 
groups at the commencement of the study. However, 
animals feed with high-fat diet showed significant increase 
in body weight compared to those feed with normal pellet 
diet (NPD) . Similarly, the average daily feed intake of all the 
groups was the same at the start of the study; however, 28-
day treatment with HFD+ treatment drug  resulted in a slight 
decrease in body weight shown in table 2 
Table 2: Body weight 
 Body weight of rats fed a high-fat diet and treated  with S. 
Grandiflora flower extracts for 7 weeks; all values are 
expressed as Mean ± SEM, (p<0.001). (a) Significant 
difference compared to control; (b) significant difference 
compared to HFD,   (one-way ANOVA, Dunnets multiple 
comparision test,  per  group). Following 2 week treatment 
with S  Grandiflora supplementation, low food intake was 
observed in the S. Grandiflora  200 mg/kg and S .Grandiflora  
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400 mg/kg groups () when compared to the HFD group. 
Subsequently, the body weight gain (at days 0, 7, 14, 21, 28,] 
[29, 35, 42, and 49) in these groups was significantly lower 
than the rats feed with HFD+ treatement drug. 
Table 3: food intake 
Food consumption (kcal) in rats fed a high-fat diet and 
treated withS.Grandiflora flower extract  for 7 weeks; all 
values are expressed as Mean ± SEM, (p<0.001) (a) 
significant difference compared to control; (b) significant 
difference compared to HFD   (one-way ANOVA, dunnets 
multiple comparision test. 
Table No 4: Effect of S.Grandiflora flower extract on liver 
parameters and blood glucose in obese rats. 
As mentioned in Table 4, it has been observed that rats feed 
on high-fat diet consecutively for 28  days resulted in a 
marked increase in the level of lipids, characterized by 
elevated levels of total cholesterol, triglycerides, LDL , and  
levels of HDL  when compared to normal control, that is, rats 
receiving the normal feed.  (Table 4) . No significant increase 
was found on the 7th and 14th days. However, treatment 
with S. Grandiflora flower extract   for 3 weeks reversed the  
hyperlipidimic  effect produced by high-fat diet significantly. 
Similar results were obtained with the standard drug 
[orlistat]. Further. Treatment with S. Grandiflora (200 mg/kg 
and 400 mg/kg) significantly reduced the body weight Effect 
of S. Grandiflora   Extract on  Blood Glucose It has been 
observed that rats receiving high-fat diet show a remarkable 
increase in blood glucose level evaluated on the 49th day . 
Treatment with extract 200 mg/kg and 400 mg/kg dose 
dependently decreased the blood glucose level (Table 4) 
Effect of S. Grandiflora Extract on Organ Weight[Table 
no 5] 
The untreated obese group showed significantly higher 
organ weight (liver) in comparison to the HFD 
group(p<0.05). Conversely, groups treated with S. 
Grandiflora flower extract at 200 mg/kg and 400 mg/kg 
showed a significantly lower organ/body weight[ Table 5] 
Histopathology of Liver in HFD Treated Rats 
Rats of control group fed with plain diet did   not   reveal  any 
lesion of pathological significant at liver. Negative control 
group[HFD] rats fed with high fat diet showed multifocal 
moderate hepatocellular vacuolation  at  liver .Treatment of 
standard drug in rats fed with high fat diet showed 
multifocal minimal hepatocellular vacuolation at liver 
.Treatment of Test drug A in rats fed with high fat diet 
showed multifocal minimal hepatocellular vacuolation at 
liver. Treatment of Test drug B in rats fed with high fat diet 
showed multifocal mild hepatocellular vacuolation at liver. 
Data presented in this report suggestive of treatment at 
negative control group produces degenerative lesions in 
hepatocytes of liver. Treatment oftest drug at Standard, Drug 
A and Drug B group mitigates the lesions liver 
 
Table 2: Effect On body weight and food intake hfd induced rat. 
Treatement group Parameter 0day 28 day 49 day 
Control Body weight 167.75±4.60** 234±2.34 218±6.64* 
Hfd control Body weight 166.75±1.75 279.25±1.65* 226±27.85 
Std orlistat Body weight 170.5±5.14 263.75±9.06** 231.25±5.83* 
200 mg/kg extract Body weight 168.5±4.66 260.75±3.83** 233.5±4.17* 
400mg/kg extract Body weight 174±7.49 277.75±3.49** 227.75±2.016** 
Result are expressed as mean ± SEM. (n=6) Data was analyzed by one-way analysis of variance (ANOVA) followed by Dunnet 
multiple comparison test. *p<0.05 and **p<0.01 when obesity control compaird with different treated group 
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Figure 1: Body weight of rats fed a high-fat diet and treated with S.Grandiflora flower extracts for 7 weeks; all values 
are expressed as Mean ± SEM, (p<0.001). (a) Significant difference compared to control; (b) significant difference 
compared to HFD P<0.001,  (one-way analysis of variance (ANOVA),Dunnets  multiple comparision test,  per group 
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Table 3: Food intake 
Treatement group Parameter 0day 28 day 49 day 
Control Food intake 17.65±0.15 16±0.34 18.18±0.92 
Hfd control Food intake 18.56±0.43 18.62±0.65* 20.23±0.63 
Std orlistat Food intake 16.70±0.27 13.48±0.92 17.95±0.98 
200 mg/kg extract Food intake 16.13±0.34 14±0.78 17.20±38 
400mg/kg extract Food intake 15.76±0.36 12.40±0.75 16.44±0.70 
Result are expressed as mean ± SEM. (n=6) Data was analyzed by one-way analysis of variance (ANOVA) followed by Dunnet 
multiple comparison test. *p<0.05 and p>0.05when obesity control compaird with different treated group. 
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Figure 2: Food intake 
Table 4: Effect of S. Grandiflora flower extract on liver parameters and blood glucose in obese rats 
SERUM 
PARAMETERS 
CONTROL 
 
HFD CONTROL 
 
STD ORLISTST  
 
200MG/KG 
EXTRACT 
400MG/KG 
EXTRACT 
TOTAL 
CHOLESTEROL 
** 
50.7± 3.107 
 
95.73±1.83 
** 
60.16±1.72 
ns 
88±1.45 
** 
60±4.57 
 
TRIGLYCERIDE 
** 
86.13±2.78 
 
222±29.66 
** 
104.9±1.704 
** 
127.33±2.839 
** 
161.23±2.40 
HIGH DENSITY 
LIPOPROTEIN 
[HDL] 
* 
43.84±4.73 
 
 
69.03±8.20 
 
* 
51.95±3.45 
 
** 
50.59±2.90 
 
** 
25.96±3.34 
 
LOW DENSITY 
LIPOPROTEIN 
 
Blood glucose mg/dl 
** 
9.66±0.29 
 
78.9±3.3** 
 
19.64±0.98 
 
94.1±4.2 
* 
11.93±0.48 
 
83±7* 
** 
17.12±1.17 
 
79.01±3.3ns 
ns 
12.91±0.97 
 
73.2±5.2*** 
Result are expressed as mean ± SEM. (n=6) Data was analyzed by one-way analysis of variance (ANOVA) followed by Dunnet 
multiple comparison test.** *p<0.001.** p<0.01 and p>0.05 ns when obesity control compaird with different treated group. 
 
Table 5: Effect of sesbania grandiflora extract on organ weight 
ORGAN WEIGHT NORMAL 
CONTROL 
HFD CONTROL STD ORLISTAT 200MG/KG 
EXTRACT 
400MG/KG 
EXTRACT 
LIVER 5.79±0.088 8.89±O.92*** 6.15±0.89** 7.56±0.77* 6.97±1.89** 
Result are expressed as mean ± SEM. (n=6) Data was analyzed by one-way analysis of variance (ANOVA) followed by Dunnet 
multiple comparison test.control* p<0.05.** p<0.01 and p>0.05 ns when obesity control compaird with different treated group. 
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Histopathological Examination  
Microscopic examination of liver showed minimal to mild focal hepatocellular infiltration of inflammatory cells in female 
animals treated with extract at 200 and 400 mg./kg body weight when compared with control group (Figure 3).and standard 
group.[figure 7] 
 
CONTROL (Fig. 3) 
 
Control liver showing normal histology Report 
P= portal triad 
H=Hepatocyte  ( H & E 400X) 
                                         
 
HFD CONTROL (Fig. 4)
 
HFD  control liver shows the hepatocellular vacuolation 
(v){H & E , 400 X} 
 
 
200MG/KG S. Grandiflora flower Extract (Fig.5) 
 
200MG/KG extract liver showing hepatocellular 
vacuolation  {v} {H &E , 400X} 
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400mg/kg extract S. Grandiflora flower Extract (Fig.6) 
 
400MG/KG extract showing  hepatocellular vacuolation {v} 
(H & E 400X) 
 
 
 
 
STANDARD- Orlistat capsule (Fig. 7) 
 
Standard liver showing  hepatocellular vacuolation {v}(H & 
E 400X) 
 
On the basis of histopathology findings, it can be concluded 
that animals treated with extract S. grandiflora flower. Data 
presented in this report suggestive of treatment at negative 
control group produces degenerative lesions in hepatocytes 
of liver. Treatment of test drug at Standard [orlistat 30mg 
capsule], Drug A [S. Grandiflora flower extract 200mg/kg] 
and Drug B[S. Grandiflora flower extract 400mg/kg] group 
mitigates the lesions incurred in liver. 
DISCUSSION 
Obesity is a major risk factor for augmenteObesity is a major 
risk factor for augmented morbidity and mortality and is 
associated with various medical ailments [11]. High fat diet-
induced obesity has been considered as the most popular 
model among researchers due to its high similarity of 
mimicking the usual route of obesity episodes in human [12]  
for studying obesity as they will readily gain weight when 
feed high-fat diets [13]. Human studies have revealed that 
increased fat intake is associated with body weight gain, 
which can lead to obesity and other related metabolic 
diseases. This study thus proved that rats exposed to high-fat 
diet for 2 weeks cause a significant increase of animals’ body 
weight, thus verifying the obese status [14]. Although there 
was a significant difference in the body weights between the 
high-fat and normal diet groups, no significant difference 
was observed in the daily food intake of animals. This 
observation provides us with the fact that an increase in 
body weight is independent of the amount of food consumed 
by the animals. Treatment of HFD rats with S.Grandiflora 
flower extract at 200 mg/kg and 400 mg/kg p.o conversely 
causes a remarkable reduction of body weights was 
observed [15]. Further, treatment with s. grandiflora  flower 
extract remarkably decreases the organ weight of rats feed 
on high-fat diet. Thus it proved the weight reducing potential 
ofS.Grandiflora flower extract. Further, dyslipidemia is 
another important hallmark in the pathogenesis of obesity 
characterized by hypertriglyceridemia with decreased level 
of LDL and VLDL [16]. Chronic dyslipidemia has been 
characterized as a major risk factor for cardiovascular risk, 
including atherosclerosis [17]. In the present study apart 
from reduction in weight, supplementation with 
S.Grandiflora flower extract and std orlistat, was observed to 
attenuate significantly the levels of total cholesterol and LDL 
and increased the level. of HDL level in rats feed with HFD. 
The increase in the level of HDL was found to be in a dose 
dependent manner; that is, supplementation with 
S.Grandiflora flower extract at a dose of 400 mg/kg shows a 
better effect in comparison to 200 mg/kg  serum HDL level 
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and decreased levels of total cholesterol, LDL, and 
triglyceride. [18]. the histopathological studies were also 
performed.  The literature review revealed that high fat diet-
induced obesity and abnormal lipid metabolism 
consumption of high-fat diet may play a crucial role in the 
pathogenesis of fatty liver or hepatic steatosis associated 
with obesity depicted via ballooning degeneration. Elevated 
levels of liver enzymes are a monitor of hepatocellular 
damage and correlate with increased liver weight [19]. 
Histological studies are used as benchmarks for determining 
pathological changes in tissues and organs. Histological 
analysis of liver (Fig. 1) revealed no abnormalities in cellular 
architecture of these vital organs in the morphology of vital 
organs. This also supports our results that liver biomarkers 
were not elevated in groups treated with S .Grandiflora  
extract. S ..Grandiflora   flowers have been widely used for 
the treatment of many ailments. Many studies have 
demonstrated their utility, including their biological 
activities, in vitro and their therapeutic benefits in rodents. 
The present study thus concludes that the extract of flowers 
of S.Grandiflora possess Anti-hyperlipidimic and antiobesity 
activity potential that protects the body against adverse 
effects of high fat diet-induced obesity. Further, we 
demonstrated that the daily supplementation of 
S.Grandiflora flower  extract may reverse the formation of 
hepatic steatosis and nonalcoholic fatty liver disorder. The 
results in the present study established that high-fat diet 
causes elevation in body weight and reduces lipid 
metabolism as clearly seen by the marked elevation of liver 
enzymes and lipid level. However, supplementation with 
S.Grandiflora flower extract reverses all the parameters thus 
suggesting its weight reducing potential. 
CONCLUSION 
Thus, from the present study it can be concluded that the 
Ethanolic Extract of the S.Grandiflora  flower extract is 
beneficial to the weight management, which supports its 
traditional claim. Further, studies are carried out in order to 
determine the active principle of this plant, followed by the 
identification of the mechanistic approach of S.Grandiflora 
that helps in weight management. This study showed that 
the administration of the S.Grandiflora flower extract to 
Wistar rats was not toxic in any of the tested doses. The 
extract did not have a direct impact on the liver and kidney 
functions as corroborated by results from hematological and 
blood sample of both sexes. Also the extract did not change  
in food and water intake.  The histology examination 
revealed no remarkable changes in the internal organs, like 
liver, of the rats, in both control and treated groups. 
Furthermore, the data of acute and sub-acute toxicity studies 
on this plant were obtained in order to increase the 
confidence in its safety to humans for the use in the 
development of pharmaceuticals. The studies also need 
further experimental activities, like sub-chronic toxicity 
study, the effect of the extract on pregnant rats, foetuses, and 
their reproductive capacity to complete the safety profile of 
this plant. 
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